HOLY STONE HEALTHCARE CO LTD has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in Taiwan, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, machines and environmental technology are DERMAN BIOMEDICINE CO LTD, PSYADON PHARMACEUTICALS INC and SUNEV PHARMA SOLUTION LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Taiwan | 7 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Brazil | 1 | |
#8 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Wu Tsung-Chung | 8 |
#2 | Lin Hua-Yang | 6 |
#3 | Lin Shyh Shyan | 3 |
#4 | Tsung Chung Wu | 2 |
#5 | Lin Shyh-Shyan | 2 |
#6 | Chang Paoho | 1 |
#7 | Wu Zong Zhong | 1 |
#8 | Wu Tsung Chung | 1 |
Publication | Filing date | Title |
---|---|---|
US2015065446A1 | Compound of glycosaminoglycan and its fabrication method as well as application | |
US2013085118A1 | Method and mixture for treating and preventing inflammatory bowel disease | |
TW201302207A | Composition for use in treating and preventing mucosa related disease | |
EP2545925A1 | Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases | |
HUE037474T2 | Composition for use in treating and preventing inflammation related disorder | |
TW201105340A | Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease | |
TW201105339A | Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer |